Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial

por Yang, Wenying, Min, Kyungwan, Zhou, Zhiguang, Li, Ling, Xu, XiangJin, Zhu, Dalong, Venkateshwar Rao, A., Murthy, Laxminarayanappa Sreenivasa, Zhang, Nianxian, Li, Ivy, Niemoeller, Elisabeth, Shang, Shuhua
Publicado 2017

Erratum. A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SEN...

por Ritzel, Robert, Harris, Stewart B., Baron, Helen, Florez, Hermes, Roussel, Ronan, Espinasse, Melanie, Muehlen-Bartmer, Isabel, Zhang, Nianxian, Bertolini, Monica, Brulle-Wohlhueter, Claire, Munshi, Medha, Bolli, Geremia B.
Publicado 2019